A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501
A Single-center, Randomized, Open-label, Two-part Study to Evaluate Bioavailability of Prototype Third-generation Formulations of E5501 Relative to Second-generation Tablet Formulation in Healthy Subjects A Single-center, Randomized, Open-label, Two-part Study to Evaluate Bioavailability of Prototype Thi ...
Idiopathic Thrombocytopenic Purpura
Drug: 10-mg dose of E5501 2G tablet;Drug: 10-mg dose of E5501 cyclodextrin oral solution;Drug: 10-mg dose of E5501-P21% powder;Drug: 10-mg dose of E5501 lipid-based oral Drug: 10-mg dose of E5501 2G tablet;Drug: 10-mg dose of E5501 cyclodextrin oral solution;Drug: 10-mg ...